J&J scraps late-stage study testing Stelara for lupus – Reuters

J&J scraps late-stage study testing Stelara for lupus – Reuters

Johnson & Johnson’s Janssen unit said on Friday it would discontinue a late-stage study testing its psoriatic arthritis drug Stelara as a treatment for lupus as it was not found to be effective against the auto-immune disease.

Read More…

You May Also Like